Harvoni prices compared U.S. vs select countries 2020

In 2020, the estimated U.S. net price for a one-month supply (28 tablets) of Harvoni Oral Tablet (90mg-400mg) was roughly 50 percent higher than gross price paid in Australia. On the other hand, gross price of Harvoni in Canada (Ontario) was roughly 50 percent higher than in the United States. However, if comparisons were made using U.S. gross price, then it was always much higher than prices in the other three countries. Harvoni is an antiviral agent, used to treat specific hepatitis C virus infections. This statistic shows Harvoni's net and gross prices in the United States compared to gross prices in Australia, Canada, and France as of 2020.

Estimated U.S. net prices of Harvoni compared to gross prices in Australia, Canada, and France as of 2020*

Characteristic	Price in U.S. dollars
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

March 2021

More information

Region

Australia, Canada, France, United States

Survey time period

as of January 2020

Supplementary notes

* Prices are for a monthly supply of Harvoni Oral Tablet 90mg-400mg (28 tablets).
Estimated U.S. net prices reflect confidential rebates and other price concessions, information on such discounts was not publicly available for the comparison countries. Thus, the actual differences between U.S. prices and those of the other countries were likely larger than GAO estimates in this statistic.

Prices for selected comparison countries—Australia, Canada (Ontario), and France—were prices listed on their respective public formularies from January 2020 and were converted to U.S. dollars at the relevant monthly Federal Reserve rates.

Citation formats